1-2 of 2
M Shahzad Rauf
Close
Sort by
Journal Articles

Long Term Survival Analysis and Impact of Risk Factors Based Survival Model in Two Hundred Patients with Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant

Saad Akhtar, M Shahzad Rauf, Tusneem Elhassan, Z A Khan, Mahmoud Elshenawy, Irfan Maghfoor
Journal: Blood
Blood (2022) 140 (Supplement 1): 10594–10595.
https://doi.org/10.1182/blood-2022-164601
Published: 2022
Journal Articles

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

Clinical Trials & Observations
Michael S. Binkley, M. Shahzad Rauf, Sarah A. Milgrom, Chelsea C. Pinnix, Richard Tsang, Michael Dickinson, Andrea K. Ng, Kenneth B. Roberts, Sarah Gao, Alex Balogh, Umberto Ricardi, Mario Levis, Carla Casulo, Michael Stolten, Lena Specht, John P. Plastaras, Christopher Wright, Christopher R. Kelsey, Jessica L. Brady, N. George Mikhaeel, Bradford S. Hoppe, Stephanie A. Terezakis, Marco Picardi, Roberta Della Pepa, Youlia Kirova, Saad Akhtar, Irfan Maghfoor, Julie L. Koenig, Christopher Jackson, Erin Song, Shuchi Sehgal, Ranjana H. Advani, Yasodha Natkunam, Louis S. Constine, Hans T. Eich, Andrew Wirth, Richard T. Hoppe
Journal: Blood
Blood (2020) 135 (26): 2365–2374.
https://doi.org/10.1182/blood.2019003877
Published: 2020
Includes: Supplemental data